DefinePK

Abstract

The term of translational medicine is used for a multidisciplinary approach to accelerate the transfer of laboratory discoveries to practical clinical application leading to the increased public health outcome. It by bridging the translational gap between the sciencific advancements and patient care, so that it precisely links scientific research to diagnostics, therapies and preventive strategies. This is a multi stage process (T1–T4, bench-to-bedside research (T1) to implementation in real world populations (T4)). translational medicine has its potential, however it is hindered by regulatory limitation, lack of funding, and adaption for various aspects of scientists collaborating with clinicians and policymakers. This framework serves a large scale validation, policy consideration and community participation role in supply unto public health. Successful translational research examples, mRNA vaccines for COVID-19 and targeted cancer therapies, demonstrate the impact of translational research. Nevertheless, insufficient allocation of resource and ethical concerns need to be addressed to ensure equity of benefits. Translational medicine is explored in this paper in terms of how it makes progress in public health, and the reasons behind the lingering failure to do so. It also describes ways of improving collaboration, funding models, and policy reforms for maximising translation of research into practice. If these efforts are strengthened, translational medicine is a means to drive innovation, reduce healthcare disparities and improve global health outcomes